ADMA Biologics Inc. (ADMA) Stock Sees Profit Taking At Higher Level: Now What?

September 9, 2021

ADMA Biologics Inc. (NASDAQ:ADMA) fell 7% after it announced the US FDA had approved VanRX SA25, its in-house aseptic fill-finish machine. According to the company, with the machine operational, it expects significant improvement in gross margins, enhanced inventory-production-cycle times, improved patient supply consistency, and increased visibility and control of commercial-product-lot launches that will create predictable revenue results in the near term. VanRx utilizes a closed isolator design that allows human…

Read More >>

ADMA Biologics Inc. (NASDAQ:ADMA) Stock falls 15% in a Month: Here are The Key Developments

September 3, 2021

ADMA Biologics Inc. (NASDAQ:ADMA) is down 15% in a month. The company that its CEO and president Adam Grossman will participate in the virtual fireside discussion at the 19th Morgan Stanley Annual Global Healthcare Conference on September 9, 2021. Recently the company released its fiscal Q2 financial results for the three months endingJune 30, 2021, and provided highlights of recent accomplishments and progress. The company realized total revenue of $17.8…

Read More >>

Adma Biologics Inc (NASDAQ:ADMA) Stock Gains After Earnings: How to Trade Now?

August 12, 2021

One of the stocks that could be on the radars of many investors today is the Adma Biologics Inc (NASDAQ:ADMA) stock. Yesterday, the company announced its financial results for the second fiscal quarter on Wednesday and since then the stock has been in focus. It has made an upward move in the premarket trading period and already gone up by as much as 4%. Although it remains to be seen…

Read More >>